Company Advanced Enzyme Technologies Limited Bombay S.E.

Equities

ADVENZYMES

INE837H01020

Specialty Chemicals

Delayed Bombay S.E. 01:08:53 2024-07-09 am EDT 5-day change 1st Jan Change
391.4 INR +0.17% Intraday chart for Advanced Enzyme Technologies Limited +6.23% +4.30%

Business Summary

Advanced Enzyme Technologies Limited is an India-based company, engaged in manufacturing enzymes and probiotics. The Company is focused on the research and development, manufacturing, and marketing of approximately 400 products, which is developed from over 68 indigenous enzymes and probiotics. It provides solutions to various industries, such as human health care and nutrition, animal nutrition, baking, fruit, and vegetable processing, brewing, and malting, grain processing, protein modification, dairy processing, textile processing and others. It offers products and solutions for human nutrition, which include serratiopeptidase, fungal lactase, fungal lipase, and papain; animal nutrition, which include DigeGrain X, DigeGrain XL and DigeGrain M; food processing, including dairy and cheese processing and yeast processing, and non-food processing, including textiles processing, leather, and biofuels. Its oils and fats processing include oil extraction, oil refining, and others.

Number of employees: 323

Sales per Business

INR in Million2023Weight2024Weight Delta
Human Nutrition
67.4 %
3,559 65.8 % 4,202 67.4 % +18.07%
Bio-process
20.9 %
1,075 19.9 % 1,307 20.9 % +21.54%
Animal Nutrition
10.9 %
710 13.1 % 677 10.9 % -4.58%
Services
1.0 %
67 1.2 % 60 1.0 % -9.49%
Reconciling Items
-0.2 %
-8 -0.1 % -12 -0.2 % +64.95%
Export Incentives
0.1 %
3 0.0 % 4 0.1 % +53.33%

Sales per region

INR in Million2023Weight2024Weight Delta
India
49.8 %
2,555 47.3 % 3,103 49.8 % +21.45%
United States
33.5 %
1,915 35.4 % 2,087 33.5 % +8.96%
Asia
7.1 %
473 8.8 % 440 7.1 % -7.11%
Europe
6.4 %
353 6.5 % 398 6.4 % +12.58%
Others
3.3 %
107 2.0 % 208 3.3 % +94.03%

Managers

Managers TitleAgeSince
Director of Finance/CFO 60 02-08-31
Compliance Officer - 17-02-13
Director/Board Member 52 14-12-07
Corporate Officer/Principal 51 05-02-28

Members of the board

Members of the board TitleAgeSince
Director/Board Member 49 19-11-01
Director/Board Member 61 22-06-30
Director/Board Member 54 16-12-13
Chairman 84 89-03-14
Director/Board Member 52 14-12-07
Director/Board Member - 19-01-07
Director/Board Member 59 19-02-08
Director/Board Member - 20-06-11
Director/Board Member - 23-06-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 111,824,075 49,760,755 ( 44.50 %) 0 44.50 %

Shareholders

NameEquities%Valuation
37,053,702 33.14 % 170 M ₹
OrbiMed Advisors Private Equity
12.08 %
13,509,522 12.08 % 62 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt)
3.331 %
3,725,132 3.331 % 17 M ₹
2,665,825 2.384 % 12 M ₹
2,646,858 2.367 % 12 M ₹
2,641,500 2.362 % 12 M ₹
1,466,000 1.311 % 7 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
0.8943 %
1,000,000 0.8943 % 5 M ₹
913,000 0.8165 % 4 M ₹
715,600 0.6399 % 3 M ₹

Company contact information

Advanced Enzyme Technologies Ltd.

A wing, Sun Magnetica LIC Service Road, Louis Wadi

400604, Thane

+91 22 4170 3200

http://www.advancedenzymes.com
address Advanced Enzyme Technologies Limited(ADVENZYMES)

Group companies

NameCategory and Sector
Pharmaceuticals: Major

Sales per Business

Sales per region

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
390.6 INR
Average target price
470 INR
Spread / Average Target
+20.33%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ADVENZYMES Stock
  4. ADVENZYMES Stock
  5. Company Advanced Enzyme Technologies Limited